# Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours

> **NCT06363201** · NA · UNKNOWN · sponsor: **Catalysis SL** · enrollment: 40 (estimated)

## Conditions studied

- Advanced Cancer
- Advanced Solid Tumor
- Lymphoma, Hodgkin
- Central Nervous System Tumor
- Sarcoma
- Germ Cell Tumor
- Pediatric Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** Ocoxin Oral solution

## Key facts

- **NCT ID:** NCT06363201
- **Lead sponsor:** Catalysis SL
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04-28
- **Primary completion:** 2024-12-15
- **Final completion:** 2025-12-15
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06363201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06363201, "Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT06363201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*